
Chief Complaint
Transplant Diagnosis : Acute myelogenous leukemia ( AML ) ( complex cytogentics refractory to chemotherapy ) . Date of Transplant : 5/6/2010 . Day Post - Transplant : 20 . Reason for admission : 5 / 3 for Cytoxan conditioning followed by PBSCT .

Interval History
Pt feeling well with essentially resolved mouth pain . Appetite improving , ate french toast this morning . Stool volume stable , 530 cc overnight . Stools are soft , form , no urgency , no abdominal pain . Ready to be discharged today . .

Pain Management
mucositis pain , now resolved . magic mouthwash PRN . . Patient Controlled Analgesics : Not applicable .
Pain Management : oxycodone available PRN .


Transplant Status
PROTOCOL / TREATMENT PLAN : 739 / 1932 .
TRANSPLANT TYPE allogeneic unrelated , matched peripheral blood stem cell transplant .
CMV SEROLOGY Donor negative , Recipient negative .
PREPARATIVE REGIMEN : Myeloablative TBI , cyclophosphamide .
GVHD Prophylaxis Methotrexate , Tacrolimus .

Allergies

NKA



Medications
Medications reviewed on 5/26/2010 .

Scheduled Medications
Acyclovir 800 mg tab Dose : 800 mg = 1 tab PO BID
Amlodipine 5 mg tab Dose : 5 mg = 1 tab PO QDay
Beclomethasone in oil ( conc 1 mg/mL ) Dose : 2 mg = 2 mL PO QID
Budesonide 3 mg cap Dose : 3 mg = 1 cap PO TID
Fluconazole 200 mg tab Dose : 400 mg = 2 tab PO QDay
Information Line Dose : Rx ready MISC QDay
Pantoprazole 40 mg tab Dose : 40 mg = 1 tab PO QDay
Tacrolimus 1 mg cap + Tacrolimus 0 . 5mg cap Dose : 1.5 mg PO Q12 Hours
Ursodiol 300 mg cap Dose : 600 mg = 2 cap PO BID
Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO QMWF
Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO QAM
Vancomycin soln ( conc 50 mg/mL ) ( ORAL ) Dose : 125 mg = 2.5 mL PO Q12 Hours
Vitamin multi with minerals , no iron tab Dose : 1 tab PO QDay

Infusions
No Infusion Medications Found .

PRN Medications
Boston butt cream 120 g Dose : 1 application Topical QDay PRN
Cepacol ( or equivalent ) lozenge Dose : 1 lozenge Mucosal Q4 Hours PRN
HydrALAZINE 20 mg/mL inj Dose : 10 mg = 0.5 mL IV Q4 Hours PRN
Lidocaine / Diphenhydra / Al - Mg hydrox 180 mL Dose : 5 mL Swish & Spit Q4 Hours PRN
Magnesium sulfate Dose : 24 mEq = 5.91 mL IVPB Q4 Hours PRN
Oxycodone 5 mg tab Dose : 5-10 mg PO Q4 Hours PRN
Sodium chloride 0.65 % nasal spray 60 mL Dose : 1 spray ( s ) Each Nostril QDay PRN





Review of Systems
CONSTITUTIONAL Symptoms
Denies fever . Denies chills . Denies malaise . Denies weakness . Denies sweats .
ENMT
Mucositis ( essentially resolved ) .
Sinus congestion ( significantly improved ) . . Denies rhinorrhea . Denies sore throat .
CARDIOVASCULAR Symptoms
Denies chest pain . Denies lightheadedness . Denies palpitations . Denies swelling .
RESPIRATORY Symptoms
Denies cough . Denies shortness of breath .
GASTROINTESTINAL Symptoms soft , loose stools , improving in consistency . , denies abdominal pain , denies nausea , denies vomiting .
GENITOURINARY Symptoms denies dysuria .
MUSCULOSKELETAL Symptoms negative .
PSYCHIATRIC Symptoms negative .
SKIN Symptoms denies itching , denies rash .
NEUROLOGIC Symptoms denies headaches , denies dizziness .
HEME / LYMPH Symptoms denies bleeding , denies bruising .


Physical Examination
Vital Signs Vital Signs Data ,
05/26/2010 08:12 Temperature - C 36.0 degC
Temperature Source Axillary
Heart Rate 104 bpm High
Respiratory Rate 18 br / min
SBP - Noninvasive 120 mmHg
DBP - Noninvasive 78 mmHg Oxygenation Data .
05/26/2010 08:12 SpO2 98 %
O2 Delivery Device Room air
I / O : .
In ; 1020
Out : 1530

Stool : 530Weight : Height / Weight / BMI - General .
05/26/2010 09:07 DAILY Weight - kg 80.2 kg CONSTITUTIONAL : well-appearing , no apparent distress .
MENTAL STATUS : alert and oriented x3 , Level of Consciousness : alert , normal mood / affect .
NECK : neck supple / non - tender .
EYES : pupils equal , round , reactive to light , extraocular movements intact , EOMI , normal sclera .
EARS , NOSE , MOUTH , and THROAT : faint erythema on bilateral buccal mucosa , mild inflammation . ulcerations on bilateral buccal mucosa almost resolved . .
MUCOSITIS ( WHO Oral Toxicity Scale ) : Grade 2 : Erythema and ulcers , patient can swallow solid diet .
RESPIRATORY / CHEST : normal respiratory effort , lung sounds clear to auscultation bilaterally . .
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop , no cyanosis or edema .
GASTROINTESTINAL : normal , normal bowel sounds , abdomen non-tender , abdomen non-distended , no hepatomegaly , no splenomegaly .
GENITOURINARY : no back / flank tenderness .
MUSCULOSKELETAL : normal gait / stance , normal strength , tone and range of motion .
SKIN : no rash , bruises or ulcers , right hickman line intact . no erythema , tenderness , inflammation . .
NEUROLOGIC : cranial nerves II - XII intact , normal sensation and coordination , strength symmetric and intact .


Laboratory Studies

Laboratory Studies ( Most recent results in 24 hour range . )

RESULTS FROM TODAY
RESULTS FROM YESTERDAY

05/26/10 00:30
05/25/10 00:30


| - ICa - - -
| - ICa - - -
140
107
16
| - Ca 9.2

141
108
14
| - Ca 9.5
- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 161
| - Mg 1.2

- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 142
| - Mg 1.2
4.6
28
0.5
| - Phos - - -

4.4
26
0.5
| - Phos - - -


RESULTS FROM TODAY
RESULTS FROM YESTERDAY

05/26/10 00:30
05/25/10 00:30


10.4
| - PT - - -
10.4
| - PT - - -
5.10 ] - - - - - - - - - - - - - - - - - - - - - - [ 83
| - INR - - -
4.40 ] - - - - - - - - - - - - - - - - - - - - - - [ 69
| - INR - - -

30
| - PTT - - -
30
| - PTT - - -


( Most recent results for 24 hour range . )
Individual Labs
05/26/2010 00:30
LD ( Total )
211
05/26/2010 00:30
AST ( GOT )
20
05/26/2010 00:30
ALT ( GPT )
11
05/26/2010 00:30
Bilirubin ( Total )
0.7
05/26/2010 00:30
Bilirubin ( Direct )
0.2
05/26/2010 00:30
Protein ( Total )
5.4
05/26/2010 00:30
Albumin
2.8
05/26/2010 00:30
MCV
84
05/26/2010 00:30
Neutrophils
3.67

Antibiotics
No Results Found .

( Most Recent Results for Prior 7 Days . )
Immunosuppressant
05/24/2010 21:40
Tacrolimus Level by LCMSMS
10

( Most Recent Results for Prior 14 Days . )
CMV Results
No Results Found .


Viral / CMV Monitoring
No results in the past 7 days .


Radiological Studies
Chest X - Ray : 5/18/10


Right internal jugular central venous catheter tip remains in the
proximal SVC . The lungs are clear . No pneumothorax or pleural effusion .
The heart size is normal and unchanged . Mild multilevel thoracic disc degeneration is present . No compression fractures .

, 5/23/10 : Findings / Impression :
Lungs clear . No pneumothorax is present . Right internal jugular
catheter are stable .
.


Consult ( s ) Requested
GI consult ordered : Date consult ordered : 5/20/10 , Evaluation of diarrhea , Rule out GVHD .


Assessment / Plan
PRIMARY DISEASE : 45 year old man with refractory AML with complex cytogenetics , now day 20 s/p MURD PBSCT with TBI / Cy conditioning .
HEMATOLOGIC : platelet threshold : 10 thousand , Hematocrit threshold : 26 % , Now engrafted . Remains anemic and thrombocytopenic but blood counts climbing and no longer needing transfusion support . .
INFECTIOUS DISEASE :
Active BACTERIAL infection / Diagnosis date : C . diff 5 / 4 stool cx . PO Vancomycin start 5 / 5 ; PO Flagyl started 5 / 6 ; switched to IV Flagyl on 5 / 7 . . .
Infection Prophylaxis : Antifungal agent ( s ) : Fluconazole , Antibacterial agent ( s ) : Trimethoprim / Sulfamethoxazole ( start on 5 / 30 ) , Antiviral agent ( s ) : Acyclovir .
Plan :
1 . C . difficile . + Cdiff from 5 / 5 ; history of recurrent Cdiff ( this is his third infection ) . Oral vancomycin started 5 / 5 ( dose increased on 5 / 7 to 500 mg PO q 6 hr ) ; PO Flagyl added 5 / 6 . Per ID recommendations , switched to IV Flagyl on 5 / 7 . Diarrhea significantly improved . Completed 10 - days of Flagyl on 5 / 16 . Vancomycin dose reduced to 250 mg PO q 6 hrs on 5 / 13 per ID recommendation . Will subsequently taper Vancomycin per taper schedule generated by Pharmacy . Diarrhea returned as of 5 / 19 , but unlikely infectious etiology as C diff from 5 / 19 negative . Now improving again .
2 . Fungal prophylaxis : Fluconazole started 5 / 26 ( stopped voriconazole , as pt without history of pulmonary nodules and treatment was empiric and likely due to prolonged cytopenias ) .
3 . Corona virus positive from 5 / 21 nasal wash PCR . Chest xray clear . Nasal congestion improving . .
Active VIRAL infection / Diagnosis date : Corona Virus 5/21/10 .
DRUG MONITORING : Tacrolimus : decreased dose ( PO FK - 506 decreased to 1.5 mg PO q 12 hrs on 5 / 24 PM . ) .
GRAFT-VERSUS-HOST DISEASE :
Active LOWER GI GVHD Assessment : Diarrhea present Estimated 24 hour stool volume : 530 ml , Differential Diagnosis : GVHD , Conditioning regimen , Infection .
Plan :
Remains on Tacrolimus since 5 / 5 . Last level on 5 / 25 : 10 . Currently at 1.5 mg PO q 12 hrs ; 5 / 27 level will be at steady state ( Voriconazole D / C 'd on 5 / 26 ) . Methotrexate given on D1 , 3 , 6 , 11 .

New onset diarrhea on 5 / 19 , EGD / Flex Sig 5 / 20 . Started empiric beclothemasone and budesonide on 5 / 20 per GI recommendations . Most likely conditioning toxicity as he is making improvement but will continue to monitor closely . Final pathology suggestive of residual chemotherapy toxicity versus early GVHD . Will continue B & B for one week upon discharge . .
REGIMEN RELATED TOXICITY :
1 . Grade 4 Mucositis , almost resolved . No longer requiring TPN or pain medication . Oral intake improving daily . .
GASTROINTESTINAL :
Diarrhea , stable and resolving . Repeat stool for C . diff negative by PCR on 5 / 19 . Stool for rotavirus , adenovirus negative ; norovirus pending . Pathology results from 5 / 20 EGD / flex sig not conclusive and differential remains early gut GVHD vs . infection vs RRT . He does seem to be improving and will monitor for now . Acid reflux , remains on Protonix daily with good control of symptoms . .
FLUIDS , ELECTROLYTES & NUTRITION : Hypomagnesemia , requiring daily IV repletion . Appetite and food intake signficantly improved . Fluid intake adquate , no IV fluids necessary . .


Comments
Discharge today . Will need FK - 506 level on Thursday , will be at steady state of 1.5 mg PO q 12 hrs dosing , but also stopped Voriconazole on 5 / 26 . Continue daily IV magnesium repletion . Monitor stool output ; continue B & B for another week . Day 28 BMA due soon . Repeat NPT in near future .


Signature

Kristen Kindsvogel , ARNP
SCCA / FHCRC Bone Marrow Transplant Service
